Earlier this month at the BioPharm America conference, the industry tipped its hat to increasingly powerful patient groups with their panel “Investments by Patient Groups and Other Stakeholders.” The panel discussed both the best practices and challenges associated with the shifting stakeholder landscape.
Although San Francisco is considered by many to be the nation’s tech hub, a new wave of digital health startups promises to put the Boston on the map as one of the nation’s most innovative cities.
The 2016 World Medical Innovation Forum hosted by Partners HealthCare highlighted emerging approaches for diagnosing, treating and managing cancer. On the final day of the conference, patient advocacy leaders discussed the role that patients and philanthropy organizations plays in driving these innovations in cancer care.
With the mHealth market estimated to reach $26 billion in the next two years, competition for funds and consumer engagement is intense. We’ve got the expert perspectives on the industry’s potential and future predictions, what they look for in companies, and tips for startups in the smartphone space.
We sat down with McCready in his office at The Boston Foundation to discuss his transition, the link between philanthropy and innovation, and his vision for the MLSC.
The annual event creates interaction between academic and startup worlds, connecting scientists and engineers with entrepreneurs, investors and innovators — with live music, of course.
The company’s exclusive monthly forums connect leading Boston VCs, angel investors and senior execs with promising health startups
Risks associated with global health markets keep companies from bringing their knowledge to places that need it the most. But for some companies, higher risks mean higher rewards.